J Sutherland

AbbVie (United States)

Papers

1

Total Citations

36

H-Index

1

About

J. Sutherland is a leading figure in automated chemical synthesis, whose work has fundamentally reshaped how pharmaceutical candidates are generated. His primary research focuses on integrating flow chemistry, purification, and sample management into unified, high-throughput platforms. Sutherland’s major contribution is the development of a flexible, robot-assisted system—centered on a Mitsubishi robotic arm—that seamlessly orchestrates synthesis, purification, and compound handling. This breakthrough, detailed in his highly cited 2013 paper (36 citations), dramatically accelerates the production of small-molecule drug candidates by eliminating manual bottlenecks and enabling round-the-clock operation. By demonstrating that complex, multi-step organic synthesis can be reliably automated, Sutherland has provided the pharmaceutical industry with a powerful tool to expedite early-stage discovery. His work not only reduces human error and increases reproducibility but also frees chemists to focus on more creative aspects of molecular design. For students and researchers, Sutherland’s platform represents a landmark achievement in the convergence of robotics and organic chemistry, offering a blueprint for the future of automated drug development.

Research Focus

Key Achievements

1
H-Index
1
Papers
36
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
An Automated Synthesis–Purification–Sample-Management Platform for the Accelerated Generation of Pharmaceutical Candidates
36 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: AbbVie (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago